121 related articles for article (PubMed ID: 17235309)
21. Efficient secretion of the herpes simplex virus tegument protein VP22 from living mammalian cells.
Mori T; Mineta Y; Aoyama Y; Sera T
Arch Virol; 2008; 153(6):1191-5. PubMed ID: 18463782
[TBL] [Abstract][Full Text] [Related]
22. Intercellular trafficking of adenovirus-delivered HSV VP22 from the retinal pigment epithelium to the photoreceptors--implications for gene therapy.
Cashman SM; Sadowski SL; Morris DJ; Frederick J; Kumar-Singh R
Mol Ther; 2002 Dec; 6(6):813-23. PubMed ID: 12498777
[TBL] [Abstract][Full Text] [Related]
23. Cytoplasm-to-nucleus translocation of a herpesvirus tegument protein during cell division.
Elliott G; O'Hare P
J Virol; 2000 Mar; 74(5):2131-41. PubMed ID: 10666242
[TBL] [Abstract][Full Text] [Related]
24. Intercellular delivery of a herpes simplex virus VP22 fusion protein from cells infected with lentiviral vectors.
Lai Z; Han I; Zirzow G; Brady RO; Reiser J
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11297-302. PubMed ID: 11027330
[TBL] [Abstract][Full Text] [Related]
25. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
[TBL] [Abstract][Full Text] [Related]
26. Engineered cell therapy for sustained local myocardial delivery of nonsecreted proteins.
Bian J; Kiedrowski M; Mal N; Forudi F; Penn MS
Cell Transplant; 2006; 15(1):67-74. PubMed ID: 16700331
[TBL] [Abstract][Full Text] [Related]
27. Intercellular trafficking of the major tegument protein VP22 of bovine herpesvirus-1 and its application to improve a DNA vaccine.
Zheng CF; Brownlie R; Huang DY; Babiuk LA; van Drunen Littel-van den Hurk S
Arch Virol; 2006 May; 151(5):985-93. PubMed ID: 16374718
[TBL] [Abstract][Full Text] [Related]
28. Intratumoral spread and increased efficacy of a p53-VP22 fusion protein expressed by a recombinant adenovirus.
Wills KN; Atencio IA; Avanzini JB; Neuteboom S; Phelan A; Philopena J; Sutjipto S; Vaillancourt MT; Wen SF; Ralston RO; Johnson DE
J Virol; 2001 Sep; 75(18):8733-41. PubMed ID: 11507218
[TBL] [Abstract][Full Text] [Related]
29. HSV-1 VP22 augments adenoviral gene transfer to CNS neurons in the retina and striatum in vivo.
Kretz A; Wybranietz WA; Hermening S; Lauer UM; Isenmann S
Mol Ther; 2003 May; 7(5 Pt 1):659-69. PubMed ID: 12718909
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy by intrahepatic and intratumoral trafficking of p53-VP22 induces regression of liver tumors.
Zender L; Köck R; Eckhard M; Frericks B; Gösling T; Gebhardt T; Drobek S; Galanski M; Kühnel F; Manns M; Kubicka S
Gastroenterology; 2002 Aug; 123(2):608-18. PubMed ID: 12145813
[TBL] [Abstract][Full Text] [Related]
31. Efficient translocation and apoptosis induction by adenovirus encoded VP22-p53 fusion protein in human tumor cells in vitro.
Roy I; Holle L; Song W; Holle E; Wagner T; Yu X
Anticancer Res; 2002; 22(6A):3185-9. PubMed ID: 12530063
[TBL] [Abstract][Full Text] [Related]
32. Cross-presentation of a human tumor antigen delivered to dendritic cells by HSV VP22-mediated protein translocation.
Chhabra A; Mehrotra S; Chakraborty NG; Mukherji B; Dorsky DI
Eur J Immunol; 2004 Oct; 34(10):2824-33. PubMed ID: 15368298
[TBL] [Abstract][Full Text] [Related]
33. Membrane association of VP22, a herpes simplex virus type 1 tegument protein.
Brignati MJ; Loomis JS; Wills JW; Courtney RJ
J Virol; 2003 Apr; 77(8):4888-98. PubMed ID: 12663795
[TBL] [Abstract][Full Text] [Related]
34. Distinctions between bovine herpesvirus 1 and herpes simplex virus type 1 VP22 tegument protein subcellular associations.
Harms JS; Ren X; Oliveira SC; Splitter GA
J Virol; 2000 Apr; 74(7):3301-12. PubMed ID: 10708447
[TBL] [Abstract][Full Text] [Related]
35. Cellular internalization of green fluorescent protein fused with herpes simplex virus protein VP22 via a lipid raft-mediated endocytic pathway independent of caveolae and Rho family GTPases but dependent on dynamin and Arf6.
Nishi K; Saigo K
J Biol Chem; 2007 Sep; 282(37):27503-27517. PubMed ID: 17644515
[TBL] [Abstract][Full Text] [Related]
36. Intercellular trafficking and enhanced in vivo antitumour activity of a non-virally delivered P27-VP22 fusion protein.
Zavaglia D; Favrot MC; Eymin B; Tenaud C; Coll JL
Gene Ther; 2003 Feb; 10(4):314-25. PubMed ID: 12595890
[TBL] [Abstract][Full Text] [Related]
37. Direct protein transfer to terminally differentiated muscle cells.
Derer W; Easwaran HP; Knopf CW; Leonhardt H; Cardoso MC
J Mol Med (Berl); 1999 Aug; 77(8):609-13. PubMed ID: 10543392
[TBL] [Abstract][Full Text] [Related]
38. The major tegument structural protein VP22 targets areas of dispersed nucleolin and marginalized chromatin during productive herpes simplex virus 1 infection.
López MR; Schlegel EF; Wintersteller S; Blaho JA
Virus Res; 2008 Sep; 136(1-2):175-88. PubMed ID: 18584907
[TBL] [Abstract][Full Text] [Related]
39. VP22 and cytosine deaminase fusion gene modified tissue-engineered neural stem cells for glioma therapy.
Jin G; Zhou Y; Chai Q; Zhu G; Xu F; Liu F
J Cancer Res Clin Oncol; 2013 Mar; 139(3):475-83. PubMed ID: 23180018
[TBL] [Abstract][Full Text] [Related]
40. Intercellular trafficking and protein delivery by a herpesvirus structural protein.
Elliott G; O'Hare P
Cell; 1997 Jan; 88(2):223-33. PubMed ID: 9008163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
